Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people worldwide.
Based on our high level of expertise in the field of ophthalmology, we seek to provide value through our products and services to meet the unmet needs of patients and the ophthalmic medical community. Our portfolio spans more than 70 products, covering a wide range of eye diseases with products now available in more than 60 countries and territories.
*1 Estimated total no. of patients to which Santen contributed (disease areas: inflammation/allergies, cornea, glaucoma, cataracts) in FY2021, calculated based on JMDC’s estimated total no. of patients for Santen’s Rx products and Santen’s shipment data. *2 Internal estimate based on external data and research.
*3 Based on FY2021 data. *4 5mL unit equivalent.
MTP & Santen 2030
Research & Development
Partnering
Therapeutic Areas
